Parisi Gray Wealth Management Sells 3,005 Shares of Danaher Corporation $DHR

Parisi Gray Wealth Management trimmed its holdings in Danaher Corporation (NYSE:DHR) by 19.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,763 shares of the conglomerate’s stock after selling 3,005 shares during the quarter. Parisi Gray Wealth Management’s holdings in Danaher were worth $2,521,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Bank Pictet & Cie Europe AG boosted its holdings in shares of Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock valued at $44,241,000 after acquiring an additional 35,730 shares during the last quarter. Tema Etfs LLC purchased a new stake in shares of Danaher during the 4th quarter valued at about $1,577,000. Strategic Wealth Partners Ltd. boosted its holdings in shares of Danaher by 14.4% during the 4th quarter. Strategic Wealth Partners Ltd. now owns 1,502 shares of the conglomerate’s stock valued at $345,000 after acquiring an additional 189 shares during the last quarter. Triavera Capital LLC purchased a new stake in shares of Danaher during the 4th quarter valued at about $8,313,000. Finally, Tidal Investments LLC boosted its holdings in shares of Danaher by 43.0% during the 4th quarter. Tidal Investments LLC now owns 75,704 shares of the conglomerate’s stock valued at $17,378,000 after acquiring an additional 22,757 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 2.6%

DHR stock opened at $190.07 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The stock has a market capitalization of $136.10 billion, a price-to-earnings ratio of 40.44, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. The firm’s fifty day simple moving average is $201.21 and its two-hundred day simple moving average is $198.78.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same quarter in the previous year, the business posted $1.72 earnings per share. The business’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is presently 27.23%.

Analyst Upgrades and Downgrades

A number of research firms have commented on DHR. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Wells Fargo & Company lowered their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 23rd. Robert W. Baird boosted their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Friday, July 18th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Finally, Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research note on Tuesday, September 2nd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $246.35.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 11.20% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.